What’s Ahead for Strategic Healthcare Acquirers in 2024
Epstein Becker Green's Kathleen Premo explores regulatory pressures and lingering COVID-19 impacts driving consolidation among smaller healthcare organizations
Healthcare
Thriving in the Evolving Healthcare Private Equity Market
How investors can foster productivity and build a back office that’s ripe for growth
Healthcare Services Sector Gains Strength
Deal activity looks likely to rise amid an overall M&A rebound; cardiology and home health and hospice are two categories to watch
Healthcare Deal Sourcing: How to Evaluate GenAI Impact on Value
Sourcescrub considers how generative AI will impact company value in the healthcare sector with important considerations for investors
Navigating the Turbulent Waters of Healthcare Mergers and Acquisitions
While labor shortages and rising bankruptcies are weighing on the healthcare sector, investors still see M&A opportunities in select niches
Healthcare Report 2023
In the first of our series of sector-focused digital reports, Middle Market Growth spotlights healthcare, highlighting trends shaping M&A opportunities within the sector.
Cell Therapy: A New M&A Frontier
Cellares co-founder and CEO Fabian Gerlinghaus shares his unique approach to developing successful cell therapies
AI Creates a Flurry of M&A Activity in Healthcare RCM and HCIT
From PE investors to strategic acquirers, AI is fueling M&A activity within RCM and HCIT
Taking the Pulse of Healthcare M&A with Twin Brook’s Tim Wentink
This episode is brought to you by Twin Brook Capital Partners, a leading direct lending finance company focused on providing cash-flow based financing solutions for the middle market private equity community
Manufacturing M&A Success Among Gene and Cell Therapy Innovators
Investors look beyond product success to overcome the supply chain challenges of lifesaving therapy development